TY  - GEN
AU  - Salim,Derya Kivrak
AU  - Mutlu,Hasan
AU  - Eryilmaz,Melek Karakurt
AU  - Musri,Fatma Yalcin
AU  - Tural,Deniz
AU  - Gunduz,Seyda
AU  - Coskun,Hasan Senol
TI  - Molecular types and neoadjuvant chemotherapy in patients with breast cancer- while molecular shifting is more common in luminal a tumors, the pathologic complete response is most frequently observed in her-2 like tumors
SN  - 2476-762X
PY  - 2015///0722
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - therapeutic use
KW  - Biomarkers, Tumor
KW  - metabolism
KW  - Biopsy, Needle
KW  - Breast Neoplasms
KW  - drug therapy
KW  - China
KW  - Databases, Factual
KW  - Female
KW  - Follow-Up Studies
KW  - Humans
KW  - Immunohistochemistry
KW  - Neoadjuvant Therapy
KW  - methods
KW  - Neoplasm Invasiveness
KW  - pathology
KW  - Neoplasm Staging
KW  - Receptor, ErbB-2
KW  - Receptors, Estrogen
KW  - analysis
KW  - Receptors, Progesterone
KW  - Retrospective Studies
KW  - Risk Assessment
KW  - Survival Analysis
KW  - Treatment Outcome
N1  - Publication Type: Comparative Study; Journal Article
UR  - https://doi.org/10.7314/apjcp.2014.15.21.9379
ER  -